|
| | Butanedioic acid, 2,3-bis(benzoyloxy)-, (2R,3R)-, compd. with (11bR)-1,2,3,6,7,11b-hexahydro-4H-pyrazino[2,1-a]isoquinolin-4-one (1:1) Basic information |
| Product Name: | Butanedioic acid, 2,3-bis(benzoyloxy)-, (2R,3R)-, compd. with (11bR)-1,2,3,6,7,11b-hexahydro-4H-pyrazino[2,1-a]isoquinolin-4-one (1:1) | | Synonyms: | Butanedioic acid, 2,3-bis(benzoyloxy)-, (2R,3R)-, compd. with (11bR)-1,2,3,6,7,11b-hexahydro-4H-pyrazino[2,1-a]isoquinolin-4-one (1:1);(R)-2,3,6,7-tetrahydro-1H-pyrazino[2,1-a]isoquinolin-4(11bH)-one (2R,3R)-2,3-bis(benzoyloxy)succinate;Butanedioic acid, 2,3-bis(benzoyloxy)-, (2R,3R)-, compd. with (11bR)-1,2,3,6,7,11b-hexahydro-4H-pyrazino[2,1-a]isoquinolin-4-one (1 | | CAS: | 1399880-37-5 | | MF: | C30H28N2O9 | | MW: | 560.56 | | EINECS: | | | Product Categories: | | | Mol File: | 1399880-37-5.mol | ![Butanedioic acid, 2,3-bis(benzoyloxy)-, (2R,3R)-, compd. with (11bR)-1,2,3,6,7,11b-hexahydro-4H-pyrazino[2,1-a]isoquinolin-4-one (1:1) Structure](CAS/20211123/GIF/1399880-37-5.gif) |
| | Butanedioic acid, 2,3-bis(benzoyloxy)-, (2R,3R)-, compd. with (11bR)-1,2,3,6,7,11b-hexahydro-4H-pyrazino[2,1-a]isoquinolin-4-one (1:1) Chemical Properties |
| | Butanedioic acid, 2,3-bis(benzoyloxy)-, (2R,3R)-, compd. with (11bR)-1,2,3,6,7,11b-hexahydro-4H-pyrazino[2,1-a]isoquinolin-4-one (1:1) Usage And Synthesis |
| Uses | D-Praziquanamine (-)-2,3-Dibenzoyl-L-tartaric Acid is an intermediate in the synthesis of (R)-Praziquantel-d11 (P702102), Unlabeled (R)-Praziquantel-d11 (P702100) has been shown to exhibit antiparasitic activity; (R)-Praziquantel is the active enantiomer of praziquantel regarding activity against juvenile S. mansoni infestations in mice. (R)-Praziquantel exhibits Schistosoma mansoni infestation inhibition in vitro and in vivo. |
| | Butanedioic acid, 2,3-bis(benzoyloxy)-, (2R,3R)-, compd. with (11bR)-1,2,3,6,7,11b-hexahydro-4H-pyrazino[2,1-a]isoquinolin-4-one (1:1) Preparation Products And Raw materials |
|
